Three CSF biomarkers reflecting the core pathological features of AD are available: T-tau (neurodegeneration), P-tau (tau hyperphosphorylation and, potentially, tangle formation), and Aβ42 (plaque pathology). This evidence concerns the gene MAPT and Alzheimer disease.